Met Life Investment Management, LLC Apellis Pharmaceuticals, Inc. Put Options Transaction History
Met Life Investment Management, LLC
- $18.1 Billion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding APLS
# of Institutions
286Shares Held
125MCall Options Held
921KPut Options Held
761K-
Wellington Management Group LLP Boston, MA12.3MShares$292 Million0.05% of portfolio
-
Avoro Capital Advisors LLC New York, NY12.2MShares$290 Million4.32% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.9MShares$282 Million20.45% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$240 Million0.0% of portfolio
-
Morgan Stanley New York, NY9.63MShares$228 Million0.02% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $2.61B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...